WO2002074287A3 - Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics - Google Patents

Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics Download PDF

Info

Publication number
WO2002074287A3
WO2002074287A3 PCT/GB2002/001162 GB0201162W WO02074287A3 WO 2002074287 A3 WO2002074287 A3 WO 2002074287A3 GB 0201162 W GB0201162 W GB 0201162W WO 02074287 A3 WO02074287 A3 WO 02074287A3
Authority
WO
WIPO (PCT)
Prior art keywords
oxapenem
antibiotics
carboxylic acids
compositions containing
antibacterial compositions
Prior art date
Application number
PCT/GB2002/001162
Other languages
French (fr)
Other versions
WO2002074287A2 (en
Inventor
Iain Simpson
Hans Rudolf Pfaendler
Original Assignee
Amura Ltd
Iain Simpson
Hans Rudolf Pfaendler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amura Ltd, Iain Simpson, Hans Rudolf Pfaendler filed Critical Amura Ltd
Priority to AU2002238778A priority Critical patent/AU2002238778A1/en
Priority to EP02704980A priority patent/EP1368010A2/en
Priority to US10/471,569 priority patent/US20040176349A1/en
Publication of WO2002074287A2 publication Critical patent/WO2002074287A2/en
Publication of WO2002074287A3 publication Critical patent/WO2002074287A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is use of an oxenpenem-3-carboxylic acid of structure (I) or (II) as define above, in combination with an antibiotic and a pharmaceutically acceptable excipient, to prepare a medicament to treat an infection in a human or animal subject caused by a bacterium which does not produce a significant amount of β-lactamase.
PCT/GB2002/001162 2001-03-15 2002-03-14 Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics WO2002074287A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002238778A AU2002238778A1 (en) 2001-03-15 2002-03-14 Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics
EP02704980A EP1368010A2 (en) 2001-03-15 2002-03-14 Antibacterial compositions which contain oxapenem-3-carboxylic acids and antibiotics
US10/471,569 US20040176349A1 (en) 2001-03-15 2002-03-14 Antibacterial composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0106428.6 2001-03-15
GBGB0106428.6A GB0106428D0 (en) 2001-03-15 2001-03-15 Antibacterial composition

Publications (2)

Publication Number Publication Date
WO2002074287A2 WO2002074287A2 (en) 2002-09-26
WO2002074287A3 true WO2002074287A3 (en) 2003-05-01

Family

ID=9910761

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/001162 WO2002074287A2 (en) 2001-03-15 2002-03-14 Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics

Country Status (5)

Country Link
US (1) US20040176349A1 (en)
EP (1) EP1368010A2 (en)
AU (1) AU2002238778A1 (en)
GB (1) GB0106428D0 (en)
WO (1) WO2002074287A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032423A1 (en) * 2000-10-19 2002-04-25 Amura Limited Pharmaceutical compositions containing oxapenem-3-carboxylic acids
AR039774A1 (en) * 2002-05-01 2005-03-02 Wyeth Corp 6-BICYCLE RENTAL-PENEMS AS BETA-LACTAMASAS INHIBITORS
AR039475A1 (en) * 2002-05-01 2005-02-23 Wyeth Corp 6-ALQUILIDEN-PENEMS TRICICLICOS AS BETA-LACTAMASA INHIBITORS
DK1557473T3 (en) * 2002-10-29 2009-05-04 Hanaki Hideaki Reagent composition to distinguish beta-lactamases, kits and methods thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108747A (en) * 1988-10-04 1992-04-28 Bayer Aktiengesellschaft Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725375A1 (en) * 1987-07-31 1989-02-09 Bayer Ag STABLE OXAPENEM-3-CARBONSAEURES
EP1199077A1 (en) * 2000-10-19 2002-04-24 Amura Limited Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
WO2002032423A1 (en) * 2000-10-19 2002-04-25 Amura Limited Pharmaceutical compositions containing oxapenem-3-carboxylic acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108747A (en) * 1988-10-04 1992-04-28 Bayer Aktiengesellschaft Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PFAENDLER, HANS RUDOLF ET AL: "Synthesis and antibacterial activity of (1'R,5R,6R)-2-tert-butyl-6-(1'- hydroxyethyl)oxapenem-3-carboxylic acid", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (1993), 3(11), 2211-18, XP008012641 *

Also Published As

Publication number Publication date
EP1368010A2 (en) 2003-12-10
AU2002238778A1 (en) 2002-10-03
US20040176349A1 (en) 2004-09-09
GB0106428D0 (en) 2001-05-02
WO2002074287A2 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
AU2002222296A1 (en) Macrolide antibiotics
MXPA02002895A (en) Topical treatment of streptococcal infections.
PT806941E (en) LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY
NZ552047A (en) Method of treatment of endobronchial infections
TWI327573B (en) 6-11 bicyclic ketolide derivatives
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
CA2351429A1 (en) 13-membered azalides and their use as antibiotic agents
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
RU94008616A (en) 2-THIOSUBLISHED CARBAPENES, INTERMEDIATE CONNECTIONS FOR OBTAINING, METHODS OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING BACTERIAL INFECTIONS
WO2003059246A3 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
ATE178798T1 (en) USE BEFORE SIMPLE OR CONJUGATED DEXTRAN IN THE PRODUCTION OF A MEDICATION TO PREVENT OR REDUCE THE RISK OF A BACTERIAL PATHOGENIC INFECTION
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
CA2483875A1 (en) 6,11 bicyclic erythromycin derivatives
HUP0400840A3 (en) Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group a and group c streptococci
WO2002074287A3 (en) Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics
EP1114826A3 (en) Novel antibacterial and prokinetic macrolides
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
AU5643299A (en) Humic acid and its use in the treatment of various conditions
GR3004655T3 (en)
EP1458391B1 (en) A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic
DE69941459D1 (en) METHOD FOR PRODUCING ESTABLISHABLE COMPOSITIONS WITH ANTIBACTERIAL ACTIVE SUBSTANCES
BRPI0411524A (en) pharmaceutical formulation of amoxicillin and clavulanate, use of sodium carboxymethylcellulose, and method of treating bacterial infection in pediatric patients
RU2002105592A (en) The method of complex prevention of anthrax
WO2005004880A8 (en) Vaginal compositions for treating pelvic tissue infections and traumas

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002704980

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002704980

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10471569

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP